LifeMD, Inc. LFMD
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2001-07-11
LifeMD, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 85.7% | 86.2% | 87.6% | 84.3% | 80.6% |
| Operating margin | -4.0% | -13.2% | -9.5% | -36.5% | -58.5% |
| Net margin | 7.4% | -13.8% | -13.5% | -38.3% | -65.6% |
| FCF margin | 3.3% | 10.4% | 5.6% | -19.6% | -35.9% |
| Return on assets | 20.4% | -28.1% | -35.2% | -177.4% | -122.0% |
| Return on equity | 62.0% | 235.7% | -491.7% | 383.6% | -267.8% |
| Current ratio | 1.25 | 0.78 | 1.22 | 0.36 | 1.97 |
| Revenue growth | 25.3% | 1.5% | 28.2% | 28.2% | 149.0% |
Source: SEC EDGAR filings · CIK 0000948320 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.